Want to learn more? Check out our

The River Stent™ and IIH

July 7, 2026
Youtube video

This webinar brings together two leading experts in neurointervention and cerebrovascular care to discuss the evolving treatment landscape for IIH, patient selection considerations, procedural insights, and real-world experience with venous sinus stenting.

The session is moderated by Dr. Brian Snelling and features Dr. Adnan Siddiqui, a renowned neurosurgeon and leader in neurovascular innovation.

Dr. Adnan Siddiqui

UB Distinguished Professor and Vice Chairman, Department of Neurosurgery SUNY Buffalo Jacobs School of Medicine and Biomedical Sciences

Dr. Adnan H. Siddiqui is a University at Buffalo Distinguished Professor and Vice Chairman of Neurosurgery at the Jacobs School of Medicine and Biomedical Sciences, internationally recognized for his expertise in cerebrovascular and endovascular neurosurgery. With specialized training in interventional neuroradiology, cerebrovascular surgery, and neurocritical care, he has extensive experience treating complex neurovascular conditions, including stroke, aneurysms, arteriovenous malformations, and venous disorders.

Dr. Siddiqui has authored more than 600 peer-reviewed publications, contributed over 50 book chapters, and delivered more than 400 presentations at leading cerebrovascular conferences worldwide. He has designed and led numerous national and international clinical trials and currently serves as principal investigator for multiple multicenter studies advancing neurovascular care and medical device innovation.

Dr. Siddiqui is Chief Executive Officer and Chief Medical Officer of the Jacobs Institute, where he works with physicians, researchers, engineers, and industry partners to accelerate the development of new technologies for vascular disease. He also directs the Canon Stroke and Vascular Research Center and the Neurosurgical Stroke Service at Buffalo’s Gates Vascular Institute, one of the busiest comprehensive stroke centers in the United States. His contributions to research, education, and innovation have earned numerous honors, including the SUNY Chancellor’s Award for Excellence in Scholarship and Creative Activities and designation as a University at Buffalo Distinguished Professor.

Dr. Brian Snelling

Director of Cerebrovascular & Endovascular Neurosurgery Medical Director, Marilyn & Stanley Barry Center for Cerebrovascular Disease and Stroke Marcus Neuroscience Institute | Boca Raton Regional Hospital

A nationally recognized researcher and educator, Dr. Snelling is board-certified by the American Board of Neurological Surgery and has authored over 50 peer-reviewed publications, book chapters, and invited editorials — with more than 2,100 citations — in journals including JAMA, the Journal of NeuroInterventional Surgery, and Neurosurgery. He is a principal investigator in multiple active national clinical trials advancing stroke care, a pioneer in transradial access for neurointerventional procedures, and has trained hundreds of surgeons in the technique.

Dr. Snelling studied at Vanderbilt University, where he earned a degree in Biomedical Engineering. He completed both his neurosurgery residency and endovascular fellowship at Jackson Memorial Hospital and the University of Miami Miller School of Medicine — one of the premier cerebrovascular and endovascular training programs in the country, under the mentorship of pioneering cerebrovascular neurosurgeon Roberto Heros, MD.

Idiopathic Intracranial Hypertension (IIH) is an underdiagnosed and undertreated disorder of elevated pressure within the brain without an identifiable cause. The IIH Practioner Series is designed for neurologists, neurosurgeons, neuro-interventionalists, endovascular surgeons, interventionist radiologists, neuroradiologists, ophthalmologists, optometrists, and ENT specialists.

Sponsored by

Novel neurovascular therapies for idiopathic intracranial hypertension (IIH)

Like what you are seeing?

Join our next webinar.

Thank you! You’re registration is complete for:

The River Stent™ and IIH

July 7 @ 8 am ET